ConductScience.org, home

Paper3325929

Ciprofloxacin for infection prevention in patients with acute leukemia.

Rozenberg-Arska M and 1 other. Pharm Weekbl Sci, 1987. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Ciprofloxacin for infection prevention in patients with acute leukemia. Papers, record 3325929. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3325929

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ciprofloxacin for infection prevention in patients with acute leukemia.
PubMed
Journal
Pharm Weekbl Sci
PubMed
Year
1987
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.08
iCite
Revised in PubMed
2019-11-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rozenberg-Arska MM
2Dekker AWA W

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial InfectionsMajor topic
CiprofloxacinMajor topic
LeukemiaMajor topic
Adult
Clinical Trials as Topic
Colistin
Drug Combinations
Drug Therapy, Combination
Humans
Random Allocation
Sulfamethoxazole
Trimethoprim
Trimethoprim, Sulfamethoxazole Drug Combination

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16842003Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.J Infect Dis1983https://conductscience.org/library/papers/6842003PubMed
23159811Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.J Infect Dis1985https://conductscience.org/library/papers/3159811PubMed
33010716Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.Am J Med1986https://conductscience.org/library/papers/3010716PubMed
46842001Antimicrobial prophylaxis against infection in neutropenic patients.J Infect Dis1983https://conductscience.org/library/papers/6842001PubMed
56794406Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia.Ann Intern Med1981https://conductscience.org/library/papers/6794406PubMed
63466563Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.Ann Intern Med1987https://conductscience.org/library/papers/3466563PubMed
76997054Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.Eur J Cancer (1965)1980https://conductscience.org/library/papers/6997054PubMed
84206836Selective elimination of Enterobacteriaceae species from the digestive tract in mice and monkeys.J Hyg (Lond)1974https://conductscience.org/library/papers/4206836PubMed
94628214Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.Ann Intern Med1972https://conductscience.org/library/papers/4628214PubMed
106660852Pharmacokinetics and tissue penetration of ciprofloxacin.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6660852PubMed
116222695In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6222695PubMed
126222896In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.Eur J Clin Microbiol1983https://conductscience.org/library/papers/6222896PubMed
136604030Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria.Infection1983https://conductscience.org/library/papers/6604030PubMed
146339052Strategies for the prevention of infection in the myelosuppressed or immunosuppressed cancer patient.Cancer Treat Rep1983https://conductscience.org/library/papers/6339052PubMed
156140347The quinolones.Lancet1984https://conductscience.org/library/papers/6140347PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
24706220Host impairments in patients with neoplastic diseases.Cancer Treat Res2014https://conductscience.org/library/papers/24706220

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3325929

GET https://conductscience.org/api/papers/v1/3325929/authors